Rémy D. Hoffmann

740 total citations
15 papers, 534 citations indexed

About

Rémy D. Hoffmann is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Rémy D. Hoffmann has authored 15 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Computational Theory and Mathematics and 3 papers in Organic Chemistry. Recurrent topics in Rémy D. Hoffmann's work include Computational Drug Discovery Methods (6 papers), Receptor Mechanisms and Signaling (5 papers) and Chemical Synthesis and Analysis (2 papers). Rémy D. Hoffmann is often cited by papers focused on Computational Drug Discovery Methods (6 papers), Receptor Mechanisms and Signaling (5 papers) and Chemical Synthesis and Analysis (2 papers). Rémy D. Hoffmann collaborates with scholars based in Austria, France and Italy. Rémy D. Hoffmann's co-authors include Thierry Langer, Marcel Hibert, Albert A. Carr, Robert C. Miller, Christian Laggner, Camille G. Wermuth, Fabian F. Moebius, Hartmut Glossmann, Peter Chiba and Gerhard F. Ecker and has published in prestigious journals such as Neuron, Journal of Medicinal Chemistry and Journal of Chemical Information and Modeling.

In The Last Decade

Rémy D. Hoffmann

15 papers receiving 502 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rémy D. Hoffmann Austria	13	315	201	151	83	77	15	534
Gregory S. Welmaker United States	15	478 1.5×	359 1.8×	176 1.2×	63 0.8×	128 1.7×	20	894
Luciana Gavernet Argentina	17	243 0.8×	236 1.2×	155 1.0×	47 0.6×	72 0.9×	44	552
Changdev G. Gadhe South Korea	15	340 1.1×	150 0.7×	170 1.1×	46 0.6×	48 0.6×	48	608
William Hageman United States	13	212 0.7×	234 1.2×	65 0.4×	40 0.5×	63 0.8×	33	610
Frank Navas United States	14	253 0.8×	209 1.0×	72 0.5×	112 1.3×	91 1.2×	20	586
Marija R. Popović-Nikolić Serbia	7	279 0.9×	177 0.9×	208 1.4×	32 0.4×	138 1.8×	16	614
Andy Vinter United Kingdom	5	233 0.7×	105 0.5×	155 1.0×	30 0.4×	60 0.8×	7	444
Anna L. Bowman United States	16	361 1.1×	135 0.7×	101 0.7×	93 1.1×	204 2.6×	22	604
Jaime Mella Chile	18	262 0.8×	338 1.7×	144 1.0×	30 0.4×	124 1.6×	56	661
Isabella M. Lico United States	5	364 1.2×	259 1.3×	196 1.3×	35 0.4×	60 0.8×	7	532

Countries citing papers authored by Rémy D. Hoffmann

Since Specialization

Citations

This map shows the geographic impact of Rémy D. Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rémy D. Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rémy D. Hoffmann more than expected).

Fields of papers citing papers by Rémy D. Hoffmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rémy D. Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rémy D. Hoffmann. The network helps show where Rémy D. Hoffmann may publish in the future.

Co-authorship network of co-authors of Rémy D. Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of Rémy D. Hoffmann. A scholar is included among the top collaborators of Rémy D. Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rémy D. Hoffmann. Rémy D. Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Langer, Thierry, Rémy D. Hoffmann, Sharon D. Bryant, & Brigitte Lesur. (2009). Hit finding: towards ‘smarter’ approaches. Current Opinion in Pharmacology. 9(5). 589–593. 21 indexed citations

Triballeau, Nicolas, Diana Cai, Peter W. Sorensen, et al.. (2008). High-Potency Olfactory Receptor Agonists Discovered by Virtual High-Throughput Screening: Molecular Probes for Receptor Structure and Olfactory Function. Neuron. 60(5). 767–774. 22 indexed citations

Steindl, Theodora M., et al.. (2007). Parallel Screening and Activity Profiling with HIV Protease Inhibitor Pharmacophore Models. Journal of Chemical Information and Modeling. 47(2). 563–571. 36 indexed citations

Langer, Thierry & Rémy D. Hoffmann. (2006). Pharmacophore modelling: applications in drug discovery. Expert Opinion on Drug Discovery. 1(3). 261–267. 40 indexed citations

Laggner, Christian, et al.. (2005). Discovery of High-Affinity Ligands of σ₁ Receptor, ERG2, and Emopamil Binding Protein by Pharmacophore Modeling and Virtual Screening. Journal of Medicinal Chemistry. 48(15). 4754–4764. 97 indexed citations

Langer, Thierry, et al.. (2004). Lead Identification for Modulators of Multidrug Resistance based on in silico Screening with a Pharmacophoric Feature Model. Archiv der Pharmazie. 337(6). 317–327. 48 indexed citations

Bertrand, Hugues‐Olivier, et al.. (2004). Structure-Based Virtual Screening: An Application to Human Topoisomerase II α. Journal of Medicinal Chemistry. 47(27). 6840–6853. 22 indexed citations

Guccione, Salvatore, et al.. (2001). A 3D QSAR Study of Monoamino Oxidase-B Inhibitors Using the Chemical Function Based Pharmacophore Generation Approach. Journal of enzyme inhibition. 16(3). 199–215. 22 indexed citations

Freyschmidt‐Paul, Pia, et al.. (2001). Guess what! Hypotrichosis simplex.. PubMed. 11(4). 383–4. 2 indexed citations

10.

Langer, Thierry & Rémy D. Hoffmann. (1998). New Principal Components Derived Parameters Describing Molecular Diversity of Heteroaromatic Residues. Quantitative Structure-Activity Relationships. 17(3). 211–223. 4 indexed citations

11.

Rival, Yveline, et al.. (1998). 5-HT₃ Antagonists Derived from Aminopyridazine-type Muscarinic M1 Agonists. Journal of Medicinal Chemistry. 41(3). 311–317. 36 indexed citations

12.

Langer, Thierry & Rémy D. Hoffmann. (1998). On the Use of Chemical Function-Based Alignments as Input for 3D-QSAR. Journal of Chemical Information and Computer Sciences. 38(2). 325–330. 16 indexed citations

13.

Rognan, Didier, et al.. (1992). Structure and molecular modeling of GABAA receptor antagonists. Journal of Medicinal Chemistry. 35(11). 1969–1977. 64 indexed citations

14.

Wermuth, Camille G., et al.. (1992). SR 46559 A and related aminopyridazines are potent muscarinic agonists with no cholinergic syndrome. Bioorganic & Medicinal Chemistry Letters. 2(8). 833–838. 17 indexed citations

15.

Hibert, Marcel, Rémy D. Hoffmann, Robert C. Miller, & Albert A. Carr. (1990). Conformation-activity relationship study of 5-HT3 receptor antagonists and a definition of a model for this receptor site. Journal of Medicinal Chemistry. 33(6). 1594–1600. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact